Effect of Orally Active Prostacyclin Analogue on Survival in Patients With Chronic Thromboembolic Pu...
Effect of Orally Active Prostacyclin Analogue on Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension Without Major Vessel Obstruction
About this item
Full title
Author / Creator
Publisher
Northbrook, IL: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Northbrook, IL: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
This study investigated whether treatment with beraprost sodium (BPS), an orally active prostacyclin analog, improves hemodynamics and survival in patients with peripheral-vessel chronic thromboembolic pulmonary hypertension (CTEPH), for which there is no surgical option.
Oral administration of BPS has been shown to improve the hemodynamics and...
Alternative Titles
Full title
Effect of Orally Active Prostacyclin Analogue on Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension Without Major Vessel Obstruction
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_73243752
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73243752
Other Identifiers
ISSN
0012-3692
E-ISSN
1931-3543
DOI
10.1378/chest.123.5.1583
